טוען...
Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?
Although upfront surgery has been the gold standard for pancreatic adenocarcinoma that is planned for resection, it should be compared with the alternative strategy of neoadjuvant therapy. Despite the many reports of the efficacy of neoadjuvant therapy, most of them were not comparative. Recently Pr...
שמור ב:
| הוצא לאור ב: | Ann Gastroenterol Surg |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105839/ https://ncbi.nlm.nih.gov/pubmed/32258974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12311 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|